Drug allergy diagnosis in humans: possibilities and pitfalls

被引:18
作者
Choquet-Kastylevsky, G [1 ]
Vial, T
Descotes, J
机构
[1] Hop Edouard Herriot, Lyon Poison Ctr, F-69437 Lyon 03, France
[2] Hop Edouard Herriot, Pharmacovigilance Unit, F-69437 Lyon, France
[3] Hop Edouard Herriot, INSERM, U503, F-69437 Lyon 03, France
关键词
drug allergy; pathophysiology; diagnosis; in vitro test; in vivo test; man;
D O I
10.1016/S0300-483X(00)00396-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Due to the potential hazards of drug allergies, an early and reliable diagnosis is crucial. The use of in in vivo tests is not recent but, because of the hazards of skin testing in patients with a history of anaphylaxis, they had been abandoned for a while. Recent reevaluations have shown that for some drugs, e.g, antibiotics-reliable skin tests can ensure the diagnosis of drug allergy in up to 70% of cases. Many in vitro tests based on well-defined mechanisms, e.g. the basophil degranulation test have been used For the diagnosis of totally unrelated allergic mechanisms. It is almost impossible to interpret their validity as diagnosis tools. Nevertheless, other rests, e.g. the lymphocyte transformation test which have been evaluated in well-conducted recent studies, seem to have a good predictive value. Their use is still restricted to clinical trials or research studies. A reliable clinical approach as well as a detailed examination of the drug intake remains obligatory to diagnose drug allergy. Available in in vivo and in vitro tests are sometimes used to confirm the diagnosis. The sensitivity and specificity of these tests is: evaluated in clinical studies. Research to improve the existing tests and to develop new diagnostic tools is still of paramount importance. (C) 2001 Published by Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:1 / 10
页数:10
相关论文
共 57 条
  • [1] ADKINSON NF, 1989, ALLERGY PRINCIPLES P, P1212
  • [2] Barbaud A, 1998, BRIT J DERMATOL, V139, P49
  • [3] Barbaud A, 1997, EUR J DERMATOL, V7, P319
  • [4] Cutaneous manifestations of adverse drug reactions
    Beltrani, VS
    [J]. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 1998, 18 (04) : 867 - +
  • [5] Breathnach S M, 1995, Australas J Dermatol, V36, P121, DOI 10.1111/j.1440-0960.1995.tb00953.x
  • [6] Breathnach SM, 1992, ADVERSE DRUG REACTIO
  • [7] Patch testing in systemic drug eruptions
    Bruynzeel, DP
    Maibach, HI
    [J]. CLINICS IN DERMATOLOGY, 1997, 15 (04) : 479 - 484
  • [8] Increased levels of interleukin 5 are associated with the generation of eosinophilia in drug-induced hypersensitivity syndrome
    Choquet-Kastylevsky, G
    Intrator, L
    Chenal, C
    Bocquet, H
    Revuz, J
    Roujeau, JC
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 1998, 139 (06) : 1026 - 1032
  • [9] Value of animal models for predicting hypersensitivity reactions to medicinal products
    Choquet-Kastylevsky, G
    Descotes, J
    [J]. TOXICOLOGY, 1998, 129 (01) : 27 - 35
  • [10] Mechanisms of drug allergy
    Coleman, JW
    Blanca, M
    [J]. IMMUNOLOGY TODAY, 1998, 19 (05): : 196 - 198